News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
779,029 Results
Type
Article (53293)
Company Profile (355)
Press Release (725367)
Multimedia
Podcasts (159)
Webinars (23)
Section
Business (219700)
Career Advice (2632)
Deals (38170)
Drug Delivery (137)
Drug Development (85822)
Employer Resources (183)
FDA (17349)
Job Trends (16156)
News (371746)
Policy (35901)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2795)
Academic (1)
Accelerated approval (31)
Adcomms (28)
Allergies (145)
Alliances (54308)
ALS (177)
Alzheimer's disease (1710)
Antibody-drug conjugate (ADC) (329)
Approvals (17579)
Artificial intelligence (589)
Autoimmune disease (147)
Automation (35)
Bankruptcy (380)
Best Places to Work (12127)
BIOSECURE Act (22)
Biosimilars (196)
Biotechnology (216)
Bladder cancer (159)
Brain cancer (61)
Breast cancer (648)
Cancer (4919)
Cardiovascular disease (422)
Career advice (2232)
Career pathing (40)
CAR-T (288)
CDC (51)
Celiac Disease (2)
Cell therapy (779)
Cervical cancer (36)
Clinical research (72799)
Collaboration (1781)
Company closure (5)
Compensation (1130)
Complete response letters (65)
COVID-19 (2895)
CRISPR (98)
C-suite (839)
Cystic fibrosis (152)
Data (6202)
Decentralized trials (2)
Denatured (53)
Depression (140)
Diabetes (513)
Diagnostics (6928)
Digital health (47)
Diversity (12)
Diversity, equity & inclusion (46)
Drug discovery (288)
Drug pricing (215)
Drug shortages (33)
Duchenne muscular dystrophy (229)
Earnings (94854)
Editorial (64)
Employer branding (23)
Employer resources (162)
Events (125394)
Executive appointments (1010)
FDA (20477)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (10)
Frontotemporal dementia (23)
Funding (1503)
Gene editing (208)
Generative AI (59)
Gene therapy (635)
GLP-1 (1063)
Government (5071)
Grass and pollen (8)
Guidances (383)
Healthcare (19870)
HIV (56)
Huntington's disease (46)
IgA nephropathy (85)
Immunology and inflammation (266)
Immuno-oncology (55)
Indications (99)
Infectious disease (3159)
Inflammatory bowel disease (200)
Inflation Reduction Act (16)
Influenza (114)
Intellectual property (245)
Interviews (455)
IPO (17147)
IRA (59)
Job creations (4390)
Job search strategy (1852)
JPM (69)
Kidney cancer (15)
Labor market (84)
Layoffs (607)
Leadership (36)
Legal (9022)
Liver cancer (93)
Longevity (15)
Lung cancer (658)
Lymphoma (377)
Machine learning (43)
Management (63)
Manufacturing (829)
MASH (169)
Medical device (14299)
Medtech (14350)
Mergers & acquisitions (22090)
Metabolic disorders (1325)
Multiple sclerosis (160)
NASH (19)
Neurodegenerative disease (333)
Neuropsychiatric disorders (93)
Neuroscience (2984)
Neurotech (1)
NextGen: Class of 2026 (7049)
Non-profit (4833)
Now hiring (65)
Obesity (631)
Opinion (317)
Ovarian cancer (166)
Pain (208)
Pancreatic cancer (226)
Parkinson's disease (290)
Partnered (37)
Patents (503)
Patient recruitment (474)
Peanut (59)
People (62903)
Pharmaceutical (95)
Pharmacy benefit managers (32)
Phase 1 (22558)
Phase 2 (31845)
Phase 3 (24039)
Pipeline (5020)
Policy (314)
Postmarket research (2902)
Preclinical (9765)
Press Release (69)
Prostate cancer (243)
Psychedelics (49)
Radiopharmaceuticals (292)
Rare diseases (862)
Real estate (6627)
Recruiting (74)
Regulatory (26283)
Reports (53)
Research institute (2556)
Resumes & cover letters (425)
Rett syndrome (26)
RNA editing (20)
RSV (77)
Schizophrenia (155)
Series A (251)
Series B (192)
Service/supplier (13)
Sickle cell disease (101)
Special edition (26)
Spinal muscular atrophy (162)
Sponsored (45)
Startups (3929)
State (2)
Stomach cancer (19)
Supply chain (109)
Tariffs (99)
The Weekly (104)
Vaccines (1072)
Venture capital (92)
Weight loss (421)
Women's health (85)
Worklife (18)
Date
Today (78)
Last 7 days (533)
Last 30 days (2440)
Last 365 days (31637)
2026 (2475)
2025 (32011)
2024 (36755)
2023 (41380)
2022 (52638)
2021 (57362)
2020 (56111)
2019 (49172)
2018 (37253)
2017 (34552)
2016 (34578)
2015 (40531)
2014 (34794)
2013 (30322)
2012 (32189)
2011 (32632)
2010 (31076)
Location
Africa (952)
Alabama (83)
Alaska (7)
Arizona (317)
Arkansas (14)
Asia (44972)
Australia (7348)
California (11264)
Canada (3274)
China (1142)
Colorado (478)
Connecticut (485)
Delaware (336)
Europe (98680)
Florida (1662)
Georgia (357)
Hawaii (3)
Idaho (64)
Illinois (899)
India (64)
Indiana (530)
Iowa (23)
Japan (427)
Kansas (127)
Kentucky (39)
Louisiana (26)
Maine (74)
Maryland (1411)
Massachusetts (8221)
Michigan (332)
Minnesota (628)
Mississippi (5)
Missouri (130)
Montana (31)
Nebraska (29)
Nevada (123)
New Hampshire (84)
New Jersey (3035)
New Mexico (31)
New York (2983)
North Carolina (1505)
North Dakota (9)
Northern California (5444)
Ohio (338)
Oklahoma (22)
Oregon (47)
Pennsylvania (2278)
Puerto Rico (22)
Rhode Island (48)
South America (1335)
South Carolina (64)
South Dakota (1)
Southern California (4381)
Tennessee (175)
Texas (1747)
United States (40334)
Utah (336)
Vermont (1)
Virginia (280)
Washington D.C. (84)
Washington State (921)
West Virginia (4)
Wisconsin (108)
Wyoming (2)
779,029 Results for "aragon pharmaceuticals inc acquired by johnson and johnson".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Johnson & Johnson reports Q4 and Full-Year 2025 results
January 21, 2026
·
20 min read
Press Releases
Johnson & Johnson Submits OTTAVA™ Robotic Surgical System to the U.S. Food and Drug Administration
January 8, 2026
·
5 min read
Press Releases
Johnson & Johnson celebrates innovation in cancer research with 2025 Dr. Paul Janssen Award
January 8, 2026
·
4 min read
Press Releases
Johnson & Johnson elevates leadership in depression with new data at 2026 American College of Neuropsychopharmacology Annual Meeting
January 13, 2026
·
27 min read
Press Releases
Johnson & Johnson Announces Quarterly Dividend for First Quarter 2026
January 5, 2026
·
1 min read
Press Releases
Halda Therapeutics Announces Acquisition by Johnson & Johnson
November 18, 2025
·
3 min read
Press Releases
Johnson & Johnson receives CHMP positive opinion for AKEEGA® (niraparib and abiraterone acetate dual action tablet) for the treatment of patients with metastatic hormone-sensitive prostate cancer (mHSPC) with BRCA1/2 mutations
February 1, 2026
·
10 min read
Press Releases
Johnson & Johnson to Host Investor Conference Call on Fourth-Quarter Results - December 15, 2025
December 16, 2025
·
1 min read
Press Releases
Johnson & Johnson submits application to the European Medicines Agency for TECVAYLI®▼ (teclistamab) in combination with DARZALEX® (daratumumab) subcutaneous formulation for patients with relapsed/refractory multiple myeloma
January 6, 2026
·
16 min read
Press Releases
Johnson & Johnson Receives FDA Approval for TRUFILL n‑BCA Liquid Embolic System for the Treatment of Symptomatic Chronic Subdural Hematoma
December 19, 2025
·
6 min read
1 of 77,903
Next
